Tada
Form: Tablet
Strength: 20mg
Generic Name: Tadalafil
Company: Eskayef Pharmaceuticals Ltd.
MRP:৳ 60.0 (Tablet)
Is Antibiotic: No
Indications
Tada is indicated for the treatment of Erectile Dysfunction (ED), Benign Prostatic Hyperplasia (BPH), or both ED and symptoms of BPH.
Pharmacology
Tada is a selective inhibitor of phosphodiesterase type 5 (PDE5). By inhibiting PDE5, Tada increases the levels of cGMP in smooth muscle cells. This helps relax the smooth muscles and increase blood flow to the penis, causing an erection. PDE5 is also found in the prostate and bladder wall, so inhibiting Tada improves blood flow and helps with urination by relaxing smooth muscles in those areas.
Dosage & Administration
Erectile Dysfunction: The recommended starting dose is 10 mg, which can be adjusted to 5 mg or 20 mg based on individual needs. The maximum dosing frequency is once a day. Tada is effective for up to 36 hours.
Benign Prostatic Hyperplasia: The recommended dose is 5 mg once daily, at the same time each day.
Combined Erectile Dysfunction and Benign Prostatic Hyperplasia: The recommended dose is 5 mg once daily, at the same time each day.
Interaction
Tada may interact with nitrates (e.g., Isosorbide, Nitroglycerin), alpha blockers, antihypertensives, alcohol, antacids, certain antifungals (e.g., Ketoconazole, Itraconazole), HIV protease inhibitors (e.g., Ritonavir), Erythromycin, Grapefruit juice, and other medications like Rifampin, Carbamazepine, Phenytoin, and Phenobarbital.
Contraindications
Tada is contraindicated for use with nitrates (e.g., Nitroglycerine, Isosorbide) due to the risk of dangerously low blood pressure. Tada should also not be used in patients with hypersensitivity to Tadalafil.
Side Effects
Common side effects include headache, indigestion, back pain, muscle pain, and nasal congestion. Rare side effects may include changes in vision, sudden vision loss, hearing loss, skin reactions like Stevens-Johnson Syndrome, and serious heart-related issues such as angina, stroke, or heart attack.
Pregnancy & Lactation
Tada has been assigned pregnancy category B by the USFDA, meaning Tada is only recommended during pregnancy if the benefits outweigh the risks. There is no data on its excretion in human milk, so caution is advised when giving Tada to breastfeeding women.
Precautions & Warnings
Precautions should be taken when using Tada in patients with angina, renal or liver impairment, bleeding problems, or those taking medications like Nitrates, alpha blockers, alcohol, or CYP3A4 inhibitors (e.g., Ritonavir, Ketoconazole, Itraconazole).
Overdose Effects
No information available on overdose effects for topical application.
Therapeutic Class
Drugs for Erectile Dysfunction.
Storage Conditions
Keep in a dry place, away from light and heat. Keep out of the reach of children.
Similar Brands of Tadalafil (Tablet – 20mg)
| Brand Name | Form | Strength | Company | MRP (৳) |
|---|---|---|---|---|
| Adafil 20 | Tablet | 20mg | Beximco Pharmaceuticals Ltd. | 60.0 |
| Celeste | Tablet | 20mg | General Pharmaceuticals Ltd. | 60.18 |
| Ciafil | Tablet | 20mg | Navana Pharmaceuticals Ltd. | 55.15 |
| Cialix | Tablet | 20mg | NIPRO JMI Pharma Limited | 60.0 |
| Ciaton 20 | Tablet | 20mg | ACI Limited | 60.18 |
| Durevolis 20 | Tablet | 20mg | Renata Limited | 60.0 |
| Edysta 20 | Tablet | 20mg | Unimed Unihealth Pharmaceuticals Ltd. | 60.0 |
| Feel 20 | Tablet | 20mg | Delta Pharma Limited | 30.0 |
| Intimate 20 | Tablet | 20mg | Square Pharmaceuticals Ltd. | 60.18 |
| kTX | Tablet | 20mg | Kemiko Pharmaceuticals Ltd. | 60.18 |
| Manlee 20 | Tablet | 20mg | Kumudini Pharma Ltd. | 50.0 |
| Nirvana 20 | Tablet | 20mg | Healthcare Pharmaceuticals Ltd. | 60.0 |
| Pawar | Tablet | 20mg | Aristopharma Limited | 60.0 |
| Penfil 20 | Tablet | 20mg | Biopharma Ltd. | 55.0 |
| Prolonga 20 | Tablet | 20mg | Pacific Pharmaceuticals Ltd. | 40.0 |
| Refeel | Tablet | 20mg | Orion Pharma Ltd. | 50.15 |
| Tealis 20 | Tablet | 20mg | Opsonin Pharma Limited | 15.0 |
| Topup | Tablet | 20mg | Euro Pharma Ltd. | 50.0 |
| Viev | Tablet | 20mg | Alco Pharma Limited | 60.18 |